Ekso Bionics enters $2M secured loan with B. Riley at 10% interest

EKSO BIONICS HOLDINGS, INC.

Agreement with B. Riley Commercial Capital for up to $2.0M secured term loan, maturing Sept 14, 2026 or upon qualified equity raise of $2.4M.
Interest at 10% per annum; exit fee of $200K (10% of principal) due at maturity.
Loan may convert into equity in connection with a qualified financing at the lead investor's price.
Existing $2.0M loan from Banc of California (Pacific Western Bank) terminated and fully paid off.
Proceeds for working capital and general corporate purposes; secured by substantially all personal property of company and subsidiary.

item 1.01item 1.02item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.